Harbin Pharmaceutical Group

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Short description Script error: No such module "Infobox".Script error: No such module "Check for conflicting parameters".Script error: No such module "Check for unknown parameters".

Harbin Pharmaceutical Group Co., Ltd. (shortened to HPGC or Hayao) is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products.[1][2][3] HPGC medication offerings include traditional Chinese medicine (TCM) and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.[4]

The company owns both Renmintongtai (Script error: No such module "Lang".), a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products.

History

File:Harbin Pharmaceutical Group Sixth Pharmaceutical Factory 01.JPG
Harbin Pharmaceutical Group Factory No. 6

In 2007, HPGC obtained approximately 73% and 14% of its total revenue from the sale of Western medicines and TCM preparations, respectively.Script error: No such module "Unsubst".

In February 2018, HPGC announced its intentions to purchase a 40% stake in GNC Holdings, Inc. for Template:Currency, following GNC's filing for Chapter 11 bankruptcy. In September 2020, it wholly acquired the company for Template:Currency.[5][6]

HPGC manufactures and distributes products for GNC China (known as Script error: No such module "Lang-zh".) under a joint venture, GNC (Shanghai) Food Technology Co., Ltd, formed in February 2019.[7]

In February 2022, HPGC was stripped of its National Enterprise Technology Center status, a state designation for enterprises identified as capable of extraordinary technology innovation, by the National Development and Reform Commission after failing to meet the previous year's qualification requirements.[8]

Harbin Pharmaceutical Group No. 6 Factory is renowned for its magnificent architecture, splendid exterior, and strong European style, earning it the nickname "The Oriental Louvre." On January 16, 2024, Harbin Pharmaceutical Group Co., Ltd. announced through its official Douyin (TikTok) account that the factory would be open to the public, and the Printmaking Museum would offer free admission. On the opening day, Harbin No. 6 Pharmaceutical Factory welcomed more than 20,000 visitors, with many waiting in line for over an hour to enter. [9]

References

<templatestyles src="Reflist/styles.css" />

  1. ↑ Script error: No such module "citation/CS1".
  2. ↑ Script error: No such module "citation/CS1".
  3. ↑ Script error: No such module "citation/CS1".
  4. ↑ Script error: No such module "citation/CS1".
  5. ↑ Script error: No such module "citation/CS1".
  6. ↑ Script error: No such module "citation/CS1".
  7. ↑ Script error: No such module "citation/CS1".
  8. ↑ Script error: No such module "citation/CS1".
  9. ↑ Script error: No such module "citation/CS1".

Script error: No such module "Check for unknown parameters".

External links

  • Script error: No such module "Official website".Script error: No such module "Check for unknown parameters". Template:In lang
  • Script error: No such module "Official website".Script error: No such module "Check for unknown parameters". Template:In lang

Template:Pharmaceutical companies of China